In 2020, the global peripheral vascular device market size was valued at $11.9 billion, with over 16 million yearly peripheral vascular procedures performed. The market size is expected to increase at a compound annual growth rate (CAGR) of 5.2% to reach $16.9 billion in 2026. Throughout this medical market research, we analyzed 113 peripheral vascular

In 2022, the European Peripheral Vascular Devices Market was valued at around €1.5 billion, and it is projected to grow at a CAGR of 3.1% during the forecast period. As a result, it is anticipated to reach approximately €1.8 billion. Throughout this medical device market research, we analyzed over 50 companies within the peripheral vascular

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

Thrombosis is defined as the formation of a blood clot inside a blood vessel, which obstructs the flow of blood. Thrombus can become life threatening if it dislodges from the vessel wall and enters the lungs or other vital organ. A fragment of thrombus traveling through the vascular system is called an embolus.

Lumen stenosis can occur due to the accumulation of thrombosis or plaque particles in a similar manner to peripheral arterial disease. The accumulation of these plaque particles has also been shown to cause calcification. Lumen stenosis is a considerable problem for both arteriovenous (AV) access surgical grafts and native fistulae because they have poor vessel patency. Due to their tendency to acquire blockages, AV access surgical grafts will require revascularization twice a year, and native fistulae will need to be cleared at least once a year.

The full report suite on the European market for Peripheral Vascular (PV) devices includes peripheral vascular stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent-grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, diagnostic and interventional catheters, standard and hydrophilic guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices.

The Chinese market for peripheral vascular devices includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, embolic protection devices, stent grafts, surgical grafts, inferior vena cava filters, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. As a result of a general increase in peripheral procedures and their relatively low cost, the market for PTA balloons will grow rapidly in China over the 2011–2018 forecast period.

The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, embolic protection devices, stent grafts, surgical grafts, IVUS catheters, inferior vena cava filters, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths and vascular closure devices. Several of these devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As a result of the general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as atherectomy devices is expected to grow rapidly in Japan over the 2011–2018 forecast period.